Indoramine
Structural formula | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General | ||||||||||||||||||||||
Non-proprietary name | Indoramine | |||||||||||||||||||||
other names |
N - {1- [2- (Indol-3-yl) ethyl] -4-piperidyl} benzamide ( IUPAC ) |
|||||||||||||||||||||
Molecular formula | C 22 H 25 N 3 O | |||||||||||||||||||||
External identifiers / databases | ||||||||||||||||||||||
|
||||||||||||||||||||||
Drug information | ||||||||||||||||||||||
ATC code | ||||||||||||||||||||||
Drug class | ||||||||||||||||||||||
Mechanism of action | ||||||||||||||||||||||
properties | ||||||||||||||||||||||
Molar mass | 347.45 g · mol -1 | |||||||||||||||||||||
Physical state |
firmly |
|||||||||||||||||||||
Melting point |
209 ° C |
|||||||||||||||||||||
safety instructions | ||||||||||||||||||||||
|
||||||||||||||||||||||
Toxicological data | ||||||||||||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Indoramin is an α 1 receptor blockers ( alpha blockers ), which as a drug for the treatment of high blood pressure is used ( antihypertensive ).
effect
The effect of indoramine is based on the expansion of the blood vessels .
Side effects
Among other things, there may be a sharp drop in blood pressure with dizziness and headaches at the beginning of treatment with indoramine. The orthostatic hypotension is characteristic of alpha blockers.
Trade names
Indoramine is available in Germany under the trade name Wydora ® .
literature
- HPT Ammon (Ed.): Hunnius Pharmaceutical Dictionary . 9th edition. Walter de Gruyter, Berlin a. New York 2004.
Individual evidence
- ↑ a b Entry on indoramine in the ChemIDplus database of the United States National Library of Medicine (NLM) .
- ↑ a b data sheet Indoramin hydrochloride from Sigma-Aldrich , accessed on April 5, 2011 ( PDF ).